Item 7.01 Regulation FD Disclosure.

On September 16, 2022, CEN Biotech Inc. (the "Company") issued a press release (the "Press Release"). The Press Release provides a business update on the launch of a new product by the Company. The Press Release is furnished hereto as Exhibit 99.1 and is incorporated by reference herein. The information contained in the Press Release is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.   Description
99.1**          Press Release
              dated September
              16, 2022.
104           Cover Page
              Interactive Data
              File (embedded
              within the
              Inline XBRL
              document)

**Furnished herewith.

© Edgar Online, source Glimpses